Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.58 |
| ▸ | BACE1 | P56817 | 3/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 3/20 | 0.52 |
| ▸ | CPA1 | P15085 | 3/20 | 0.52 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.51 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29834943 | 1.00 | MME (0.58) | MMEBACE1NAALAD2ACECPA1 | |
| SCHEMBL29630435 | 0.96 | MME (0.60) | MMEBACE1NAALAD2LTA4HSLC15A1 | |
| SCHEMBL31206426 | 0.96 | MME (0.58) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL30494635 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL11548564 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL668395 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL8761646 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL135366 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL29525004 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 | |
| SCHEMBL10618864 | 0.96 | MME (0.61) | MMENAALAD2ACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912785-B2 | Peptide compositions for slowing degradation of vitamin mineral supplements, foods, pharmaceutical and cosmetics | BAILEY STEVEN W (US) | 2024-02-27 | — | — | US | claimed |
| EP-0297560-B1 | Imides; a process for their production and a process for the production of dipeptides using them | AJINOMOTO KK (JP) | 1998-03-04 | — | — | EP | claimed |
| US-20240247028-A1 | PEPTIDE COMPOSITIONS FOR SLOWING DEGRADATION OF VITAMIN MINERAL SUPPLEMENTS, FOODS, PHARMACEUTICAL AND COSMETICS | BAILEY STEVEN W (US) | 2024-07-25 | — | — | US | disclosed |
| US-11912785-B2 | Peptide compositions for slowing degradation of vitamin mineral supplements, foods, pharmaceutical and cosmetics | BAILEY STEVEN W (US) | 2024-02-27 | — | — | US | disclosed |
| EP-0248416-B1 | METHOD FOR RECOVERING ALPHA-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER | AJINOMOTO CO., INC. (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0538882-A1 | Novel 2,5-dioxopiperazine compounds and method for preparing alpha-aspartyl-L-phenylalanine methyl ester derivatives | Ajinomoto Co., Inc. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0248416-A2 | Method for recovering alpha-L-aspartyl-L-phenylalanine methyl ester | AJINOMOTO CO., INC. (JP) | 1987-12-09 | — | — | EP | disclosed |
| US-4345091-A | Method of producing N-benzyloxycarbonyl-L-aspartic acid | AJINOMOTO COMPANY INCORPORATED (JP) | 1982-08-17 | — | — | US | disclosed |